What were Pfizer's second-quarter adjusted earnings per share, and how did they compare to analyst expectations?

Pfizer reported adjusted earnings of 77 cents per share for the second quarter, exceeding analysts' estimates of 68 cents per share, according to LSEG data.

How much additional cost savings did Pfizer announce, and over what timeframe does it expect to realize them?

Pfizer announced an additional $2.5 billion in cost savings, expected to be realized between 2027 and 2029, building on its ongoing cost-cutting efforts to offset declining COVID-related revenue and restore sustainable growth.

Pfizer Beats Earnings Estimates, Targets $2.5 Billion in Additional Cost Cuts

Aug 4, 2026

Pfizer reported better-than-expected Q2 earnings driven by Eliquis sales and announced $2.5 billion in cost cuts through 2029. The company aims to offset declining COVID revenue while expanding into the obesity market via Metsera acquisition.

reuters

2026-02-12

UK Law Firms Eye Legal Action Against Pfizer Over Contraceptive-Linked Brain Tumours

2026-06-10

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-18

Pfizer CFO Dave Denton to step down, leave company in August

2026-06-23

China Outpacing Europe in Drug Innovation and Development, Pfizer Executive Says

2026-07-10

Polish Air Traffic Control Faces Funding Freeze Over COVID Vaccine Ruling